Similar articles

• Ocular leprosy.

  Grzybowski A, Nita M, Virmond M. Grzybowski A, et al. Clin Dermatol. 2015 Jan-Feb;33(1):79-89. doi: 10.1016/j.clindermatol.2014.07.003. Clin Dermatol. 2015. PMID: 25432813 Review.
• Multidrug therapy and after: changing visage of ocular leprosy.

  Daniel E. Daniel E. Int J Lepr Other Mycobact Dis. 1994 Sep;62(3):437-9. Int J Lepr Other Mycobact Dis. 1994. PMID: 7963919 No abstract available.
• [Ocular complications of leprosy].

  Verin P, Yacoubi M, Berbich A, Morax S. Verin P, et al. Bull Soc Ophtalmol Fr. 1971 Apr;71(4):504-9. Bull Soc Ophtalmol Fr. 1971. PMID: 5148489 French. No abstract available.
• The prevalence of disabling ocular complications of leprosy: a global study.

  Ffytche TJ. Ffytche TJ. Indian J Lepr. 1998 Jan-Mar;70(1):49-59. Indian J Lepr. 1998. PMID: 9598405
• The epidemiology of ocular complications of leprosy.

  Courtright P. Courtright P. Indian J Lepr. 1998 Jan-Mar;70(1):33-7. Indian J Lepr. 1998. PMID: 9598403 Review. No abstract available.